169 related articles for article (PubMed ID: 38680050)
1. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
Reed J; Dong T; Eaton E; Friswold J; Porges J; Al-Kindi SG; Rajagopalan S; Neeland IJ
Diabetes Obes Metab; 2024 Jul; 26(7):2881-2889. PubMed ID: 38680050
[TBL] [Abstract][Full Text] [Related]
2. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
3. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
Martens T; Beck RW; Bailey R; Ruedy KJ; Calhoun P; Peters AL; Pop-Busui R; Philis-Tsimikas A; Bao S; Umpierrez G; Davis G; Kruger D; Bhargava A; Young L; McGill JB; Aleppo G; Nguyen QT; Orozco I; Biggs W; Lucas KJ; Polonsky WH; Buse JB; Price D; Bergenstal RM;
JAMA; 2021 Jun; 325(22):2262-2272. PubMed ID: 34077499
[TBL] [Abstract][Full Text] [Related]
4. Impact of Self-Monitoring Blood Glucose on Glycaemic Control Among Insulin-Treated Patients With Diabetes Mellitus in Northeastern Tanzania: A Randomised Controlled Trial.
Muhali SS; Muhali FS; Mfinanga SG; Sadiq AM; Marandu AA; Kyala NJ; Said FH; Nziku EB; Mirai TE; Ngocho JS; Mlay HL; Waria GG; Chambega A; Kessy SN; Kilonzo KG; Lyamuya FS; Mkwizu EW; Shao ER; Chamba NG
J Diabetes Res; 2024; 2024():6789672. PubMed ID: 38899147
[No Abstract] [Full Text] [Related]
5. Intermittently scanned continuous glucose monitoring provides no benefit over structured self-monitoring of blood glucose in type 2 diabetes not on prandial insulin, in the context of diabetes self-management education: GLucose monitoring programme SingaporE (GLiMPSE).
Rama Chandran S; Rahman N; Gandhi M; Tan NC; Phoon IKY; Seah DEJ; Cheah MH; Sek K; Gardner DS
Diabetes Res Clin Pract; 2024 May; 211():111678. PubMed ID: 38642860
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
7. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
8. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
9. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose monitoring systems for type 1 diabetes mellitus.
Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
[TBL] [Abstract][Full Text] [Related]
11. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
[TBL] [Abstract][Full Text] [Related]
12. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
[TBL] [Abstract][Full Text] [Related]
13. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
[TBL] [Abstract][Full Text] [Related]
14. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
[TBL] [Abstract][Full Text] [Related]
15. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
16. Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya.
Marbán-Castro E; Muhwava L; Kamau Y; Safary E; Rheeder P; Karsas M; Kemp T; Freitas J; Carrihill M; Dave J; Katambo D; Kimetto J; Allie R; ; ; Ndungu J; Sigwebela N; Akach D; Girdwood S; Erkosar B; Nichols BE; Haldane C; Vetter B; Shilton S
Trials; 2024 May; 25(1):331. PubMed ID: 38773658
[TBL] [Abstract][Full Text] [Related]
17. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
18. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.
Battelino T; Bergenstal RM; Rodríguez A; Fernández Landó L; Bray R; Tong Z; Brown K
Lancet Diabetes Endocrinol; 2022 Jun; 10(6):407-417. PubMed ID: 35468321
[TBL] [Abstract][Full Text] [Related]
20. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
